Association of absolute amount of pattern 4 disease on prostate biopsy with oncologic outcomes in intermediate-risk prostate cancer

A systematic review

Authors

  • Melissa Sam Soon University of Ottawa
  • Scott C. Morgan Division of Radiation Oncology, Department of Radiology, Radiation Oncology and Medical Physics, University of Ottawa and the Ottawa Hospital, Ottawa, ON, Canada
  • Luke T. Lavallee Division of Urology, Department of Surgery, University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada
  • Rodney H. Breau Division of Urology, Department of Surgery, University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada
  • Trevor A. Flood Department of Anatomical Pathology, University of Ottawa and the Ottawa Hospital, Ottawa, ON, Canada
  • Mark T. Corkum Division of Radiation Oncology, Department of Radiology, Radiation Oncology and Medical Physics, University of Ottawa and the Ottawa Hospital, Ottawa, ON, Canada

DOI:

https://doi.org/10.5489/cuaj.8995

Keywords:

Gleason, Pattern 4, Outcomes, Prostate cancer

Abstract

INTRODUCTION: Managing intermediate-risk prostate cancer is challenging due to the heterogeneity in patient outcomes within this risk category. Evaluating the absolute amount of Gleason pattern 4 disease (GP4) at biopsy using the total linear length of pattern 4 (GP4- TL) or absolute percentage of pattern 4 (APP4) may enhance risk stratification. This review aimed to determine if these absolute measures predict oncologic outcomes in IRPC and to identify optimal prognostic thresholds.

METHODS: A systematic review was conducted following PRISMA guidelines. Studies included were those reporting the absolute amount of GP4 on biopsy and related outcomes in IRPC patients undergoing surgery or radiotherapy. Outcomes included biochemical recurrence, androgen deprivation therapy (ADT)-free survival, distant metastasis, prostate cancer-specific mortality, all-cause mortality, and adverse pathology.

RESULTS: Seven studies with a total of 2523 patients were included. Analysis revealed that APP4 thresholds were highly predictive of biochemical recurrence, ADT-free survival, and distant metastasis. Both APP4 and GP4-TL were superior to relative % GP4 and Gleason grading (4+3 vs. 3+4) in predicting disease progression and mortality.

CONCLUSIONS: The absolute amount of GP4 shows consistent associations with important clinical outcomes and offers an accessible and established method to enhance risk stratification. Further research is needed to define optimal thresholds to guide treatment decisions.

Downloads

Download data is not yet available.

Downloads

Published

2025-02-24

How to Cite

Sam Soon, M., Morgan , S. C. ., Lavallee, L. T. ., Breau, R. H., Flood, T. A. ., & Corkum , M. T. . (2025). Association of absolute amount of pattern 4 disease on prostate biopsy with oncologic outcomes in intermediate-risk prostate cancer: A systematic review. Canadian Urological Association Journal, 19(6), 211–6. https://doi.org/10.5489/cuaj.8995

Issue

Vol. 19 No. 6 (2025): CUAJ June

Section

Review

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.